GSK3B and major depressive disorder: Kozlovsky et al. [236] showed borderline reduction in dorsolateral prefrontal cortical mRNA levels of GSK3β, but not GSK3α, in patients with schizophrenia compared to other comparison groups [bipolar disorder, unipolar depression, and normal controls].